Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool
Related Posts
Hoffman R, Walker D, Butler D, Tseng CH, Shoptaw S, Currier JS, Gladstein J, Moucheraud C. High usage of telephone telemedicine among people living with[...]
Rana AI, Castillo-Mancilla J, Landovitz RJ. Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges. Reply. N Engl J Med. 2026 May 14;394(19):1963-1964. doi:[...]
Liu L, Branda JA, Azzato F, Klausner JD, Kersh EN, Pasricha S, Allan-Blitz LT. Comparing Phenotypic Susceptibility Profiles of Neisseria gonorrhoeae for Tetracycline and Doxycycline.[...]